Hypothalamic-Pituitary-Adrenal Axis Response to Oral Naltrexone in Alcoholics during Early Withdrawal

Abstract

Introduction: It is thought that naltrexone may play a significant role in the regulation of the hypothalamic-pituitary-adrenal (HPA) axis response to stress. We investigated the HPA axis response following single-dose oral naltrexone administration in the early phase of alcohol withdrawal.

Methods: Cortisol and adrenocorticotrophic hormone (ACTH) responses to naltrexone were measured in alcohol-dependent males (n=23) and in healthy males (n=20). Blood samples were collected for cortisol and ACTH measurements before administering (0 min) 50 mg naltrexone at 08.00 in the morning, and at 60, 90, 120 and 180 min after administering naltrexone.

Results: Naltrexone administration resulted in a significant ACTH response in the patients while cortisol and ACTH responses were found to be significant in the controls. Cortisol response was not large enough to reach significance in the patients. ACTH level changes as a response to naltrexone in the patients were lower than that in the controls.

Discussion: The study revealed blunted cortisol and attenuated ACTH responses to naltrexone in early alcohol withdrawal. This study may have shown impairment in adrenal and pituitary levels during alcohol withdrawal.

Key words

Naltrexone - HPA axis - cortisol - ACTH - alcohol withdrawal

• References

• 1 King AC, Schluger J, Gunduz M et al. Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism. Neuropsychopharmacology 2002; 26: 778-788
• 2 Naber D, Pickar D, Davis GC et al. Naloxone effects on beta-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers. Psychopharmacology (Berl) 1981; 74: 125-128
• 3 Kreek MJ, Schaefer RA, Hahn EF et al. Naloxone, a specific opioid antagonist, reverses chronic idiopathic constipation. Lancet 1983; 1: 261-262
• 4 Cohen MR, Cohen RM, Pickar D et al. High-dose naloxone infusions in normals. Dose-dependent behavioral, hormonal, and physiological responses. Arch Gen Psychiatry 1983; 40: 613-619
• 5 Conaglen JV, Donald RA, Espiner EA et al. Effect of naloxone on the hormone response to CRF in normal man. Endocr Res 1985; 11: 39-44
• 6 Delitala G, Trainer PJ, Oliva O et al. Opioid peptide and alpha-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man. J Endocrinol 1994; 141: 163-168
• 7 Schluger JH, Ho A, Borg L et al. Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism. Alcohol Clin Exp Res 1998; 22: 1430-1436
• 8 Adinoff B, Junghanns K, Kiefer F et al. Suppression of the HPA axis stress-response: implications for relapse. Alcohol Clin Exp Res 2005; 29: 1351-1355
• 9 Junghanns K, Backhaus J, Tietz U et al. Impaired serum cortisol stress response is a predictor of early relapse. Alcohol Alcohol 2003; 382: 189-193
• 10 Junghanns K, Tietz U, Dibbelt L et al. Attenuated salivary cortisol secretion under cue exposure is associated with early relapse. Alcohol Alcohol 2005; 401: 80-85
• 11 Ray LA, Mackillop J, Leggio L et al. Effects of naltrexone on cortisol levels in heavy drinkers. Pharmacol Biochem Behav 2009; 91: 489-494
• 12 Kemper A, Koalick F, Thiele H et al. Cortisol and beta- endorphin response in alcoholics and alcohol abusers following a high naloxone dosage. Drug Alcohol Depend 1990; 25: 319-326
• 13 Volavka J, Mallya A, Bauman J et al. Hormonal and other effects of naltrexone in normal men. Adv Exp Med Biol 1979; 116: 291-305
• 14 Farren CK, O’Malley S, Grebski G et al. Variable dose naltrexone-induced hypothalamic-pituitary-adrenal stimulation in abstinent alcoholics: a preliminary study. Alcohol Clin Exp Res 1999; 23: 502-508
• 15 O’Malley SS, Krishnan-Sarin S, Farren C et al. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. Psychopharmacology 2002; 160: 19-29
• 16 American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. 4th edition text revision Washington DC: American Psychiatric Association; 2000
• 17 Selzer ML. The Michigan Alcoholism Screening Test (MAST): The quest for a new diagnostic instrument. Am J Psychiatry 1971; 127: 1653-1658
• 18 Sullivan JT, Swift RM, Lewis DC. Benzodiazepine requirements during alcohol withdrawal syndrome: Clinical implications of using a standardized withdrawal scale. J Clin Psychopharmacol 1991; 11: 291-295
• 19 Krishnan-Sarin S, Rounsaville BJ, O’Malley SS. Opioid receptor antagonists: Naltrexone and Nalmafene. In Sadock BJ, Sadock VA. editors. Kaplan&Sadock’s Comprehensive Texbook of Psychiatry. 8. Edition 2007
• 20 Martin del Campo AF, Dowson JH, Herbert J et al. Effects of naloxone on diurnal rhythms in mood and endocrine function: a dose-response study in man. Psychopharmacology 1994; 114: 583-590
• 21 Kiefer F, Jahn H, Otte C et al. Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?. Biol Psychiatry 2006; 60: 74-76
• 22 Inder WJ, Joyce PR, Ellis MJ et al. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: Interaction with endogenous opioid peptides. Clin Endocrinol (Oxf) 1995; 43: 283-290
• 23 Adinoff B, Krebaum SR, Chandler PA et al. Dissection of hypothalamic-pituitary-adrenal axis pathology in 1-month-abstinent alcohol-dependent men, part 2: response to ovine corticotropin-releasing factor and naloxone. Alcohol Clin Exp Res 2005; 29: 528-537
• 24 Costa A, Bono G, Martignoni E et al. An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics. Psychoneuroendocrinology 1996; 21: 263-275
• 25 Lee S, Schmidt ED, Tilders FJ et al. Effect of repeated exposure to alcohol on the response of the hypothalamic-pituitary-adrenal axis of the rat: I. Role of changes in hypothalamic neuronal activity. Alcohol Clin Exp Res 2001; 25: 98-105
• 26 Ozsoy S, Esel E. Hypothalamic-pituitary-adrenal axis activity, dehydroepiandrosterone sulphate and their relationships with aggression in early and late alcohol withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 340-347
• 27 Ehrenreich H, Schuck J, Stender N et al. Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence. Alcohol Clin Exp Res 1997; 21: 1285-1293
• 28 Fries E, Hellhammer DH, Hellhammer J. Attenuation of the hypothalamic-pituitary-adrenal axis responsivity to the Trier Social Stress Test by the benzodiazepine alprazolam. Psychoneuroendocrinology 2006; 31: 1278-1288